These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 12761581)
1. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells. Petak I; Vernes R; Szucs KS; Anozie M; Izeradjene K; Douglas L; Tillman DM; Phillips DC; Houghton JA Cell Death Differ; 2003 Jun; 10(6):729-39. PubMed ID: 12761581 [TBL] [Abstract][Full Text] [Related]
2. Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. Petak I; Douglas L; Tillman DM; Vernes R; Houghton JA Clin Cancer Res; 2000 Oct; 6(10):4119-27. PubMed ID: 11051265 [TBL] [Abstract][Full Text] [Related]
3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
4. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A; Lam A; Datta R; Srivastava RK Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196 [TBL] [Abstract][Full Text] [Related]
5. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K; Douglas L; Delaney AB; Houghton JA Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213 [TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. Lamothe B; Aggarwal BB J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810 [TBL] [Abstract][Full Text] [Related]
8. Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. LeBlanc H; Lawrence D; Varfolomeev E; Totpal K; Morlan J; Schow P; Fong S; Schwall R; Sinicropi D; Ashkenazi A Nat Med; 2002 Mar; 8(3):274-81. PubMed ID: 11875499 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling. Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112 [TBL] [Abstract][Full Text] [Related]
10. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. Weng C; Li Y; Xu D; Shi Y; Tang H J Biol Chem; 2005 Mar; 280(11):10491-500. PubMed ID: 15637055 [TBL] [Abstract][Full Text] [Related]
11. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid. Werner AB; de Vries E; Tait SW; Bontjer I; Borst J J Biol Chem; 2002 Oct; 277(43):40760-7. PubMed ID: 12196516 [TBL] [Abstract][Full Text] [Related]
12. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H; Bouchon A; Stahl H; Krammer PH Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456 [TBL] [Abstract][Full Text] [Related]
14. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
15. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells. Ruiz-Ruiz C; López-Rivas A Biochem J; 2002 Aug; 365(Pt 3):825-32. PubMed ID: 11936954 [TBL] [Abstract][Full Text] [Related]
16. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N; El-Deiry WS Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450 [TBL] [Abstract][Full Text] [Related]
17. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415 [TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097 [TBL] [Abstract][Full Text] [Related]
19. Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway. Lee YJ; Song JJ; Kim JH; Kim HR; Song YK Exp Cell Res; 2004 Feb; 293(1):129-43. PubMed ID: 14729063 [TBL] [Abstract][Full Text] [Related]
20. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]